From the author of "Toxic Psychiatry" and "Talking Back to Prozac"
"Peter Breggin is the conscience of American psychiatry. Once
more he updates us on the real evidence with respect to the safety
and effectiveness of specific psychiatric medications and ECT. This
information is needed by all mental health professionals, as well
as patients and families." --Bertram Karon, Ph.D., Professor of
Psychology, Michigan State University, Author of "The Psychotherapy
of Schizophrenia" "Nowhere does false medical thinking do more harm
than in the modern psychiatric argument that mental illness is
easily diagnosed and then cured by a side-effect free drug. Nowhere
is the correct psychiatric thinking more evident than in the books
by Peter Breggin." -- William Glasser, MD, psychiatrist, author of
"Reality Therapy"
In "Brain Disabling Treatments in Psychiatry," renowned
psychiatrist Peter R. Breggin, M.D., presents startling scientific
research on the dangerous behavioral abnormalities and brain
dysfunctions produced by the most widely used and newest
psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor,
Xanax, Ativan, Ritalin, Adderall, Concerta, Strattera, Risperdal,
Zyprexa, Geodon, Abilify, lithium and Depakote.
Many of Breggin's earlier findings have improved clinical
practice, led to legal victories against drug companies, and
resulted in FDA-mandated changes in what the manufacturers must
admit about their drugs. Yet reliance on these drugs has continued
to escalate in the last decade, and drug company interests have
overwhelmed psychiatric practice.
This greatly expanded second edition, supported by the latest
evidence-based research, shows that psychiatric drugs achieve their
primary or essential effect by causing brain dysfunction, and that
they tend to do far more harm than good.
New scientific analyses in this completely updated edition
include:
Chapters covering every new antidepressant and stimulant drug
Twenty new guidelines for how to conduct non-drug therapy A chapter
describing how to safely withdraw from psychiatric drugs A
discussion of "medication spellbinding," explaining how patients
fail to appreciate their drug-induced mental dysfunctions
Documentation of how the drug companies control research and the
flow of information about psychiatric treatments
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!